RxDoctor Payments Data

Travis Moulton, DO

Family Medicine · Caldwell, IDNPI 1760744403

Payments from drug & device makers

$625in general payments, 2019–2025

Across 34 payments — averaging $18.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$108
  • AbbVie$90
  • Exeltis, USA Inc.$77
  • Novo Nordisk$76
  • Dexcom, Inc.$49
  • Boehringer Ingelheim$34
  • plus $191 from 10 others

What the payments were for

  • Food & beverage$61098%
  • Education$152%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$625 in reported general payments places this provider in the 65th percentile of 803 family medicine providers in Idaho.

See all family medicine providers in Idaho

Medicare billing

Part B allowed, 2024
$98,028
Medicare patients
223
Services billed
4,160

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide133$227,637
EliquisApixaban178$212,246
OzempicSemaglutide127$184,609
FarxigaDapagliflozin Propanediol149$169,985
JardianceEmpagliflozin63$86,749
JanuviaSitagliptin Phosphate60$75,676
MounjaroTirzepatide29$56,595
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog52$46,812
RybelsusSemaglutide19$37,021
Trelegy ElliptaFluticasone/Umeclidin/Vilanter35$34,087
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog16$29,959
Tresiba Flextouch U-200Insulin Degludec14$26,140
Nurtec OdtRimegepant Sulfate11$20,369
XareltoRivaroxaban14$19,502
VraylarCariprazine Hcl13$17,600

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Nurtec Odt$22$232,615189 claims
Novo NordiskOzempic, Rybelsus$76$221,630146 claims
Boehringer IngelheimJardiance, Spiriva Respimat, Combivent Respimat$34$99,70389 claims
MerckJanuvia$16$75,67660 claims
AbbVieVraylar$90$17,60013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 803 family medicine providers in Idaho.

Other family medicine in Caldwell

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →